Pharma Industry
Industry: Email Alert RSS FeedLevitra of benefit to diabetic men
Pharma Marketletter, June, 2004
Unlike the global erectile dysfunction drug market leader, Pfizer's Viagra (sildenafil), Bayer/GlaxoSmithKline's Levitra (vardenafil) appears to be of benefit to diabetic men, according to the results of studies presented at the American Diabetes Association in Orlando, Florida, a factor which could help the latter firms in their fight for market share of the huge ED market; Viagra's annual sales are in the region of $2 billion.
Men being treated for diabetes are three times more likely to have ED than those in the general population. In addition, more than 50% of diabetic men develop ED within 10 years of being diagnosed with diabetes, and the condition tends to be difficult to treat in diabetic men, notes a Bayer/GSK press statement.
Study results showed...
Brought to you by CBS MoneyWatch.com
- 10 Best Places to Retire
- Companies with the Best 401(k) Plans
- Most Important Document for Your Heirs? It's Not Your Will
- Video: Should You Expect to Retire Rich?
- Over 50? Here's How to Get (and Keep) a Great Job
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- La anemia falciforme - causas y tratamiento
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions

